Additionally, exogenous expression of cyclophilin A reduces NRP‐1 and VEGF mRNA expression levels, which could provide benefits as combination therapy.73 However, further research into the mechanism of lytic peptides against cancer cells and the potential side effects is warranted. Here, NRP1 is linked to cancer.